New studies indicate Paxlovid does not relieve long COVID symptoms im adults or prevent condition in teenagers

Reports: Paxlovid doesn't relieve adult long-COVID symptoms, prevent condition in youth Tomorrow, pharmaceuticals will no longer be exempt from the Trump administration's 25% tariff on goods produced in Canada. CIDRAP

A pair of new studies finds no significant benefit of the antiviral drug nirmatrelvir-ritonavir (Paxlovid) in alleviating the symptoms of adult long-COVID patients or in preventing the development of the condition in adolescents.

..